Updated Nov 4, 2026FDA and CMS public dataIndependent · free · not health advice
GxRadar
Drugs/Omeprazole DR 20 mg capsule
Stomach acid

Omeprazole DR 20 mg capsule

Public data on omeprazole from CMS and FDA: what pharmacies have paid for it, how many generic applications FDA has approved, and whether it appears in FDA's shortage or recall records.

$0.0305
NADAC per ea (2026-11)
approximate acquisition cost, not a retail price
-18%
change over five years
peak $0.0883 in 2014-02
31
approved generic applications (ANDAs) on record for Omeprazole
24 with a product still marketed · first 2002
Not listed
in FDA's current shortage list
no matching FDA shortage entries

NADAC per unit, monthly

OMEPRAZOLE DR 20 MG CAPSULE
Show as table
MonthNADAC per unit ($)
2013-110.06624
2014-020.08833
2014-050.07066
2014-080.07365
2014-110.06672
2015-020.06325
2015-050.06476
2015-080.06285
2015-110.05802
2016-020.05866
2016-050.05039
2016-080.04784
2016-110.04756
2017-020.04619
2017-050.04703
2017-080.04289
2017-110.04724
2018-020.04984
2018-050.04162
2018-080.04513
2018-110.04078
2019-020.03871
2019-050.03896
2019-080.04154
2019-110.04182
2020-020.04172
2020-050.04226
2020-080.04171
2020-110.03999
2021-020.04058
2021-050.03982
2021-080.03745
2021-110.03728
2022-020.03398
2022-050.03789
2022-080.03446
2022-110.03434
2023-020.03311
2023-050.03379
2023-080.03197
2023-110.03293
2024-020.03626
2024-050.03038
2024-080.03329
2024-110.03011
2025-020.03192
2025-050.03324
2025-080.03196
2025-110.03071
2026-020.02946
2026-050.02853
2026-080.02768
2026-110.03045

Source: CMS NADAC weekly files, generic rows, monthly median of weekly averages · data as of 2026-11. Figures can change and may contain errors in the source data. Check the original source before relying on them.

Recall records mentioning omeprazole

openFDA enforcement records, by year reported.

20253
20242
20231
20226
20217
20201
20192
20162
20154
20144

34 records since 2012. A record is one product or lot, not one recall event. Combination products that contain omeprazole are included.

What these numbers mean

NADAC is what retail pharmacies pay on average to buy the drug, published by CMS. It does not include rebates and is not what you pay at the counter. ANDA counts include all strengths and forms and applications whose products are now discontinued.

Most recent recall records

Class IIOngoing
Omeprazole delayed-release capsules
Reason category: Sterility / contamination
FDA recall number D-0525-2025
Class IIOngoing
Esomeprazole magnesium oral suspension
Reason category: Impurities (e.g. nitrosamines)
FDA recall number D-0442-2025
Class IIOngoing
Esomeprazole magnesium oral suspension
Reason category: Impurities (e.g. nitrosamines)
FDA recall number D-0443-2025
Class IIIOngoing
Esomeprazole magnesium oral suspension
Reason category: Labeling or packaging error
FDA recall number D-0102-2025
Class IICompleted
Omeprazole product
Reason category: Potency out of spec
FDA recall number D-0355-2024

Not health advice. GxRadar is for general information only. Nothing here is medical, pharmacy, legal or financial advice. Do not start, stop or change any medicine based on this site. Talk to your pharmacist or prescriber about your own situation.

Articles that mention omeprazole

15 GxRadar articles cite or discuss this drug.

OMEPRAZOLE · NADAC
Price histories · Data story · 6 min

What pharmacies paid for omeprazole, pantoprazole and famotidine

Pharmacy costs for generic omeprazole and pantoprazole fell by more than half from 2013 to 2026. Prescription famotidine jumped 68 percent after the 2020 ranitidine withdrawal, then fell back below its 2013 level.

Labels & identifiers · Explainer · 6 min

What "Rx only" on a drug label means

The symbol traces to a 1951 amendment and a 1997 rewrite of federal drug law. How a drug lands on either side of the prescription line, and how molecules from loratadine to naloxone crossed it.

2020
Case histories · History · 6 min

The ranitidine withdrawal of 2020

How NDMA findings in ranitidine moved FDA from lot recalls in 2019 to a request in April 2020 that every maker pull the drug, and what the recall records and later research show.

Generic or brand · Explainer · 6 min

Extended-release, delayed-release and immediate-release pills, and how FDA judges their generics

ER, XL, DR and the rest describe how a pill lets go of its drug. What the formulations are, how FDA tests generic copies of each, what the Orange Book codes say, and what our recall data show.

PRICE INDEX · 2014 = 100
Price histories · Data story · 6 min

The generics that cost pharmacies more than they did in 2014

Most generics in GxRadar's 47-drug basket got cheaper. Seven cost pharmacies more than in January 2014, led by furosemide at 2.8 times its 2014 price. What federal cost and shortage data show, drug by drug.

PRICE INDEX · 2014 = 100
Price histories · Data story · 5 min

What pharmacies pay for a month of common generics

Thirty tablets of each of the 10 most-used generics we track cost pharmacies $35.70 in January 2014 and $8.80 in October 2026. That is acquisition cost, and the rest of the price sits on top of it.